1. Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands. (22nd September 2022) Authors: de Jongh, Felix E.; Efe, Reva; Herrmann, Kirsten H.; Spoorendonk, Jelle A. Other Names: Singh Arjun Academic Editor. Journal: International journal of breast cancer Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PP62 Recommendations On Methodologies To Obtain Comparator Efficacy In Health Economic Assessments Of Tumor-Agnostic Drugs. (23rd December 2022) Authors: Efe, Reva; Vijgen, Sylvia Journal: International journal of technology assessment in health care Issue: Volume 38(2022)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗